Simmaron’s Solve ME/CFS Catalyst Award-Winning Rapamycin Trial Yields Promising Treatment Findings
Dr. Avik Roy is the chief scientific officer at the Simmaron Research Institute, a non-profit organization dedicated to understanding ME/CFS and related diseases and to treating people with these diseases. […]
Targeting Autophagy: A Clinical Trial of Low-Dose Rapamycin for ME/CFS, Long COVID, and IACCIs
Simmaron Research is the second recipient of Solve’s ME/CFS Catalyst Award in support of its study,” “Low Dose Rapamycin in ME/CFS, Long-COVID, and Other Infection-Associated Chronic Conditions.” Read a preprint […]
Solve Selects Simmaron Research As Recipient of ME/CFS Catalyst Award to Accelerate Low-Dose Rapamycin Trial for ME/CFS, Long COVID, and IACCs
Dr. C. Gunnar Gottschalk and Dr. Avik Roy Solve M.E. is proud to announce that we’ve selected the Simmaron Research Institute as the winner of our second Solve ME/CFS Catalyst […]
Ampligen: A General Overview and the Plan for ME/CFS & Long Covid
For the second installment in our clinical diagnostics and treatments webinar series, Solve M.E. welcomes two leaders from bio-pharma company AIM ImmunoTech to discuss their plans for clinical studies of […]
